CDEK by Data4ThePeople
Sign in Sign up
← All organizations

IsoRay Medical, Inc.

For profitWebsite ↗

Also known as: IsoRay Medical, Inc. | Perspective Therapeutics

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jun 1, 2020

Last known activity

Jun 30, 2025

Acquired by Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting on Oct 9, 2022

Timeline

2000s

  1. Jun 1, 2004

    IsoRay Medical, Inc.— Founded

2020s

  1. Oct 9, 2022

    Viewpoint Molecular Targeting— Acquired By

  2. Oct 9, 2022

    Viewpoint Molecular Targeting— Now

  3. Oct 18, 2022

    Viewpoint Molecular Targeting— Acquired

Drugs by trial phase (6 distinct, 7 trials)

Phase 1 (0 own, 2 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Richland, WA, US Jun 1, 2004
Last known activity
Jun 30, 2025